Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report

When Johnson & Johnson’s Xarelto entered the market in 2011 and Bristol Myers Squibb’s Eliquis did the same in 2013, list prices for the popular blood thinners were $218 and $250, respectively, for a monthly supply.